Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Bird

Showing results (81-90 of 190) with videos related to

Pageof 19
Sort By:
Disease Models & Mechanisms|February 18, 2022
TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegansCaitlin S Latimer, Jade G Stair, Joshua C Hincks, et al.
Brain Pathology (Zurich, Switzerland)|July 16, 2008
Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patientsKevin Duerson, Randall L Woltjer, Paramita Mookherjee, et al.
Parkinsonism & Related Disorders|July 2, 2022
Reduced gene dosage is a common mechanism of neuropathologies caused by ATP6AP2 splicing mutationsWilliam C Edelman, Kostantin Kiianitsa, Tuhin Virmani, et al.
Acta Neuropathologica|September 4, 2025
Down syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer's diseaseJordan Ogg, Nadia Postupna, Laura E Gibbons, et al.
Archives of Neurology|April 13, 2005
Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindredsDong-Hui Chen, Mark Matsushita, Shirley Rainier, et al.
Journal of the Neurological Sciences|July 17, 2010
A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutationsDong-Hui Chen, Wendy H Raskind, William W Parson, et al.
Archives of Neurology|April 17, 2008
Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer diseaseHans Basun, Nenad Bogdanovic, Martin Ingelsson, et al.
Muscle & Nerve|May 31, 2013
Longitudinal features of STIR bright signal in FSHDSeth D Friedman, Sandra L Poliachik, Randolph K Otto, et al.
Acta Neuropathologica|December 6, 2008
A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesionsC Dirk Keene, Rubens C Chang, James B Leverenz, et al.
Human Molecular Genetics|July 4, 2013
Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cellsGregory J Block, Divya Narayanan, Amanda M Amell, et al.
Pageof 19

Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Disease Models & Mechanisms|February 18, 2022
TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegansCaitlin S Latimer, Jade G Stair, Joshua C Hincks, et al.
Brain Pathology (Zurich, Switzerland)|July 16, 2008
Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patientsKevin Duerson, Randall L Woltjer, Paramita Mookherjee, et al.
Parkinsonism & Related Disorders|July 2, 2022
Reduced gene dosage is a common mechanism of neuropathologies caused by ATP6AP2 splicing mutationsWilliam C Edelman, Kostantin Kiianitsa, Tuhin Virmani, et al.
Acta Neuropathologica|September 4, 2025
Down syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer's diseaseJordan Ogg, Nadia Postupna, Laura E Gibbons, et al.
Archives of Neurology|April 13, 2005
Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindredsDong-Hui Chen, Mark Matsushita, Shirley Rainier, et al.
Journal of the Neurological Sciences|July 17, 2010
A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutationsDong-Hui Chen, Wendy H Raskind, William W Parson, et al.
Archives of Neurology|April 17, 2008
Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer diseaseHans Basun, Nenad Bogdanovic, Martin Ingelsson, et al.
Muscle & Nerve|May 31, 2013
Longitudinal features of STIR bright signal in FSHDSeth D Friedman, Sandra L Poliachik, Randolph K Otto, et al.
Acta Neuropathologica|December 6, 2008
A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesionsC Dirk Keene, Rubens C Chang, James B Leverenz, et al.
Human Molecular Genetics|July 4, 2013
Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cellsGregory J Block, Divya Narayanan, Amanda M Amell, et al.
Pageof 19